IONIS PHARMACEUTICALS INC 4

Joan E. Herman received 5,220 Ionis Pharmaceuticals (IONS) shares upon vesting of a Restricted Stock Unit award, increasing her direct holdings to 51,306 shares.

On July 15, 2026, Joan E. Herman reported the vesting and settlement of 5,220 Restricted Stock Units (RSUs) into Ionis Pharmaceuticals, Inc. common stock, recorded on the Form 4 as a transaction with code “M” and an acquisition (“A”) of shares. Each RSU represents the right to receive one share of common stock or its cash equivalent, and these units vested and were delivered in accordance with a prior RSU award that vests 100% on the first anniversary of grant or the next annual meeting, with settlement on the following July 15. Following this vesting event, Herman’s direct ownership in Ionis common stock increased to 51,306 shares. There is no sale or open‑market purchase involved; this is a routine equity compensation vesting with no price paid by the insider and no explicit transaction value disclosed in the filing.

Filing Facts

CIK

874015

Ticker

IONS

Form

4

Source Type

fda

Accession

0000874015-26-000245

Alert Tier

5